The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 15, 2019
Filed:
Jun. 22, 2017
Applicant:
Cornell University, Ithaca, NY (US);
Inventors:
John W. Babich, New York, NY (US);
James M. Kelly, Ithaca, NY (US);
Alejandro Amor-Coarasa, Ithaca, NY (US);
Shashikanth Ponnala, Ithaca, NY (US);
Assignee:
Cornell University, Ithaca, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/17 (2006.01); C07C 275/16 (2006.01); A61K 31/19 (2006.01); A61K 51/10 (2006.01); G01N 33/574 (2006.01); G01N 33/60 (2006.01); A61K 51/04 (2006.01); C07B 59/00 (2006.01); C07F 7/22 (2006.01);
U.S. Cl.
CPC ...
A61K 31/17 (2013.01); A61K 31/19 (2013.01); A61K 51/0402 (2013.01); A61K 51/1072 (2013.01); C07B 59/001 (2013.01); C07C 275/16 (2013.01); C07F 7/2208 (2013.01); G01N 33/57434 (2013.01); G01N 33/57492 (2013.01); G01N 33/60 (2013.01); C07B 2200/05 (2013.01); G01N 2500/04 (2013.01);
Abstract
The present technology is directed to compounds, compositions, medicaments, and methods related to the treatment of cancers expressing PSMA. The compounds are of Formulas I & II or pharmaceutically acceptable salts thereof. The present technology is especially well-suited for use in treating prostate cancer.